Halia is a clinical-stage biopharmaceutical company discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. 

We do this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses.

Halia Therapeutics, Inc.

Engaged employees are the life blood of your organization and there is some risk when you have highly engaged team members.

Listen to David Bearss Ph.D. from Halia Therapeutics, Inc. describe the double edged sword of employee engagement and the reality that the work of developing life-saving drugs is really hard.

Listen to my full podcast conversation with Dave, Nick Dyer and Simon Arkell OLY at one of the links in the first comment.

#ceo #lifescience #employeeengagement

Don't miss this episode of "Conversations Life Science Leaders Aren't Having!"  Host Jeff Harmon leads a critical discussion with life science executives Nick Dyer (Project Constellation Holdings), Dave Bearss (Halia Therapeutics), and Simon Arkell (Ryght). They delve into the complex connection between employee engagement and performance in the life sciences industry, exploring how to drive organizational success through a motivated workforce.

Listen to the episode at: https://loom.ly/DqfEC8c

 #employeeengagement #lifesciences

This is a great study that just came out today in the journal Nature. As we age, our immune system changes and these changes are driven by a shift in the populations of blood stem cells. When we are young, we have a balance between the "adaptive" lineage of cells, which produces antibodies and T cells targeted to specific pathogens, and the "innate" lineage that regulates responses, such as inflammation. When we are old, this balance shifts to the inflammatory side, and this drives changes that are associated with aging. Irv Weissman’s group at Stanford University has shown in this publication that if you can get rid of skewed stem cells and restore balance to the populations of blood stem cells, you could also rejuvenate the immune system.

BioUtah President and CEO, Kelvyn Cullimore, will take the stage as part of the One Utah Summit, April 11-12. He will be sharing insights on the future of Utah's economy alongside esteemed colleagues from other focus industries. Join Kelvyn at this impactful event and use promo code KELVYN25 for an exclusive discount on your ticket. Let's connect and elevate the conversation together!

https://lnkd.in/gvyNgA9u

Halia Therapeutics CEO, David Bearss, will be speaking at Asia Bio Partnering Forum 2024, taking place in Singapore, April 24—25, 2024! Join us and over 1,000 life science leaders! Register now >> https://loom.ly/wDf8IXM

#chronicinflammation #NLRP3 #inflammasome #inflammaging #longevity

Halogen Group is a company specializing in risk intelligence and security solutions.

Halogen Group

Exscientia is a drug discovery and development company utilizing AI and automation.

Exscientia

Synthego is a company providing genetic engineering solutions.

Synthego

Haliatx is a biotechnology company that specializes in the discovery and development of novel therapeutics. The company leverages cutting-edge research in halogen chemistry to create innovative treatments for various diseases.

Haliatx

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	May 8, 2024 9:55 AM	fcf94326
public peers	general	May 8, 2024 9:55 AM	de9bba0c
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 8, 2024 9:55 AM	636e4bad
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	fcbe0c4d
crunchbase profile	general
li profile	general	May 8, 2024 9:55 AM	3edca3f8
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 8, 2024 9:55 AM	43a5ba1b
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:HALIATX

Haliatx